ELISA Kit for Anterior Gradient Protein 2 (AGR2)Homo sapiens (Human)Sandwich ELISA

GOB4; HAG2; XAG2; AG2; PDIA17; HPC8; Protein Disulfide Isomerase Family A,Member 17; Secreted cement gland protein XAG-2 homolog

  • Product No.SEC285Hu
  • Organism SpeciesHomo sapiens (Human)Same name, Different species.
  • Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
  • Test MethodDouble-antibody Sandwich
  • Assay Length3h
  • Detection Range1.56-100ng/mL
  • SensitivityThe minimum detectable dose of this kit is typically less than 0.62ng/mL.
  • Specificity This assay has high sensitivity and excellent specificity for detection of Anterior Gradient Protein 2 (AGR2).
    No significant cross-reactivity or interference between Anterior Gradient Protein 2 (AGR2) and analogues was observed.
  • ApplicationsEnzyme-linked immunosorbent assay for Antigen Detection.
  • DownloadInstruction Manual
  • Format48T96T96T*596T*1096T*100
  • FOBUS$ 490US$ 700US$ 3150US$ 5950US$ 49000
  • ELISA Kit for Anterior Gradient Protein 2 (AGR2)Package and Components
  • ELISA Kit for Anterior Gradient Protein 2 (AGR2)Package and Components
  • ELISA Kit for Anterior Gradient Protein 2 (AGR2)Results demonstration
  • SEC285Hu.jpgTypical Standard Curve
  • CertificateISO9001: 2008, ISO13485: 2003 Registered

Recovery

Matrices listed below were spiked with certain level of recombinant Anterior Gradient Protein 2 (AGR2) and the recovery rates were calculated by comparing the measured value to the expected amount of Anterior Gradient Protein 2 (AGR2) in samples.

MatrixRecovery range (%)Average(%)
serum(n=5)78-9689
EDTA plasma(n=5)86-10298
heparin plasma(n=5)86-9590

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anterior Gradient Protein 2 (AGR2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anterior Gradient Protein 2 (AGR2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anterior Gradient Protein 2 (AGR2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample1:21:41:81:16
serum(n=5)80-99%84-93%94-105%98-105%
EDTA plasma(n=5)90-99%92-104%96-105%80-103%
heparin plasma(n=5)83-104%80-89%78-90%94-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

ReagentsQuantityReagentsQuantity
Pre-coated, ready to use 96-well strip plate1Plate sealer for 96 wells4
Standard2Standard Diluent1×20mL
Detection Reagent A1×120µLAssay Diluent A1×12mL
Detection Reagent B1×120µLAssay Diluent B1×12mL
TMB Substrate1×9mLStop Solution1×6mL
Wash Buffer (30 × concentrate)1×20mLInstruction manual1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

ELISA Kit for Anterior Gradient Protein 2 (AGR2)

Test principle

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Anterior Gradient Protein 2 (AGR2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Anterior Gradient Protein 2 (AGR2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Anterior Gradient Protein 2 (AGR2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Anterior Gradient Protein 2 (AGR2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Reference

  • Cancer BiomarkersSerum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinomaMetaPress: n7137r6271u54118
  • Molecular & Cellular ProteomicsIntegrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer BiomarkersPubMed: PMC3205865
  • Prostate.Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotypePubmed: 22911164
  • BMC Cancer.Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9Pubmed: 24007603
  • Clinical Cancer ResearchValidation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic CancerPubmed:25239611
  • PLoS OneAGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer DetectionPubMed: 25875093